1. November

2019

Trump nominates MD Anderson oncologist as U.S. FDA Commissioner

Reuters

Home
Aktuelles
Trump nominates MD Anderson oncologist as U.S. FDA Commissioner

Litigation & Dispute Resolution partner Christopher Mikson (Washington DC) was quoted in this article.

Beratungsfelder

Praxis –

Public Policy, Regulatory & Political Law

Branchen –

Aktuelles

2. Mai

2022

Raj De and Andrew Olmem named among "Washington's Most Influential People" by Washingtonian
22. Februar

2022

Mayer Brown represents Dobson Fiber in partnership with iCON Infrastructure
16. Februar

2022

Mayer Brown advises Elkay Manufacturing on $1.56 billion acquisition by Zurn Water Solutions
3. Februar

2022

Litigator joins Mayer Brown’s growing Salt Lake City office
11. Januar

2022

Mayer Brown advises CDPQ on $3 billion investment in Invenergy Renewables from Blackstone Infrastructure Partners